Home
Why we exist
The world is no stranger to allergies and the conditions they trigger. From environmental to food allergies, from asthma to eczema.
It is a quiet, yet massive epidemic - larger than depression, hypertension and even diabetes.
And, it’s only getting worse.
The world is no stranger to allergies and the conditions they trigger. From environmental to food allergies, from asthma to eczema.
It is a quiet, yet massive epidemic - larger than depression, hypertension and even diabetes.
And, it’s only getting worse.
We are Nectar
and we are putting
an end to allergies
We believe
great science can be delivered without compromising consumer experience.
Meet the Team
We are a group of seasoned executives that have come together with a common purpose - putting an end to allergies.
Experience:
EVP Ancestry and Founder & GM AncestryDNA and Pfizer
What made you decide to come work for Nectar?The rush of starting with a problem that needs to be solved and a blank whiteboard, building a great team, developing a strategy, launching a product and helping people live a better life.
Nectar's Medical Advisory Board
Shyam Joshi, MD
Section Chief, Allergy and Immunology, Oregon Health and Science University
Mohamed Shamji, PhD
Faculty of Medicine, National Heart & Lung Institute, Imperial College London
Michael S. Blaiss, MD, FACAAI, FAAAAI
Clinical Professor, Medical College of Georgia at Augusta University
John Zwetchkenbaum, MD
Chief Allergist and Founder of AAPRI, Warwick, RI
Nectar is backed by
Founded by Patrick Chun and Jed Cairo in 2015, Juxtapose is an inception-stage investment firm that is exclusively focused on building industry-transforming businesses from the ground up. The fund has supported the creation and financing of technology companies such as Care/of, Tend, Orchard, Great Jones, DayForward, and Modern Age. Juxtapose partners with the world's most experienced and talented entrepreneurial operators to found and scale category-defining technology companies that are set up to win in the industries in which they operate.
Read more at juxtapose.com
Obvious Ventures is a venture capital firm investing in startups and entrepreneurs reimagining trillion-dollar industries through a world-positive lens. Since launching in 2014, Obvious has backed over 90 companies using technology to create a smarter, healthier, more sustainable world. The fund has led investments in breakthrough companies such as Beyond Meat, Olly, Virta Health, and Recursion. Obvious was co-founded by Ev Williams, James Joaquin, and Vishal Vasishth.
More information is available at obvious.com
Harmony Partners is a highly differentiated venture capital firm that makes expansion stage investments in high growth software, internet and tech- enabled companies. By eliminating the typical deal constraints of traditional growth equity firms around minimum check sizes and ownership percentages, Harmony fills a gap in the market. Harmony helps entrepreneurs craft ideal financings, minimize founder dilution, and save time & effort, while accommodating outsized insider appetite and making room for strategic partners. Based in New York City but investing globally, Harmony was founded in 2010 by Mark Lotke who has invested $1 billion in over 100 technology companies over the past 25 years, including Anaplan, AppDynamics, Alation, Arctic Wolf, E*Trade, Iterable, Klaviyo, Maven Clinic, Natera, Postmates, Priceline, SS&C,, Swiggy, UiPath, and Zerto.
To learn more, please visit www.harmonyvp.com
